The number of known inherited defects of pyrimidine metabolism is small. At least for a part this may be due to the fact that there is no typical end product, such as uric acid in purine metabolism. Furthermore, urinary pyrimidines are not easily accessible for simple chromatographic screening. However, metabolites such as uracil, thymine and orotic acid can be detected with the routine gas-liquid chromatography procedure for organic acids using ethyl acetate extraction and trimethylsitylation (Wadman et aI., 1984) if their concentrations are strongly elevated. By this method we established a persistently excessive excretion of thymine and uracil in a 4-year-old boy, whose urine was screened for inborn errors of metabolism. Later another patient was discovered in the same way. In a third patient the same abnormality was found using 2-dimensional thin layer chromatography according to van Gennip et al. (1978) . This metabolite profile suggested a deficiency of dihydropyrimidine dehydrogenase (EC 1.3.1.2) (DHPDH) as the underlying deIect. The main site of DHPDH is th6 liver, but the enzyme has also been demonstrated in leukocytes (Goedde et al., 1968) . In the present paper the establishment of DHPDH-deficiency in the leukocytes of the three patients is described. Excretory levels of thymine, uracil and of a third metabolite, 5-hydroxymethyluracil, are given.
PATIENTS
Index patient, R.E.*, a boy, diagnosed at the age of 4 years had transient seizures, speech retardation and behavioural problems. When he grew older he developed favourably. The first child of the family is healthy, the second one died of perinatal asphyxia. The second patient, M.S., a girl and only child of parents who are first cousins, was diagnosed at the age of 14 years. Clinical features are mental retardation, solitary behaviour and epileptic absences. The third patient, a Turkish boy, B.B., was presented for screening at the age * Presented at the poster session of the international meeting 1980 at Interlaken of 15 months because of severe growth retardation, diarrhoea and feeding difficulties. Mentally the child seems to be retarded. A second child of the family is normal.
METHODS
Urinary pyrimidines were determined by automated cation exchange column chromatography, using a Technicon TSMI autoanalyser combined with a Schoeffel model SF 770 UV spectroflow monitor (10 mm cell, wavelength setting 260 nm), an Infotronics CRS 309 integrator and a printer. The column (39.5cm, dia. 5ram) was packed with Technicon spherical resin Chromobeads C3 (12 g). Urine volume applied 10 gl; pump rate 0.45 mlmin-1. Elution was performed with sodium citrate (0.066 M) HCI buffers according to the following scheme. Buffer 1 : pH 3.40, 50°C, 24 rain. Buffer 2: pH 4.00, 50°C, 32 rain. Buffer 3: pH 6.60, 50°C, 68 rain. NaOH 0.2M, 12rain. Buffer 1: 22rain. The retention times of 5-hydroxymethyluracil was 24rain; uracil, 28.5 rain; thymine, 37 rain. DHPDH activity in leukocytes was determined by the method of Piper et al. (1980) , a radiochemical procedure measuring the production of [methyl-3H]dihydrothymine from [methyl-3H ]thymine after separation by paper chromatography.
RESULTS
All three patients excreted persistently excessive amounts of uracil (2.0-10.5 mmot (g creatinine)-t), thymine (2.3-7.5 mmol (g creatinine)-1) as well as substantial quantities of 5-hydroxymethyluracil (0.2-0.9retool (g creatinine)-1 ), a metabolite of thymine. In normal urine uracil is below 0.30retool (g creatinine) -1, whilst thymine and 5-hydroxymethyluracil are not detected. Parents and sibs and a normal profile of their urinary pyrimidines.
After loading index patient R.E. with uracil, 1 mmol (kg b.wt)-1, 74 % of the administered dose was excreted during 24 h. When dihydrouracil was given only 7 % of the load was excreted unaltered during 24 h and no free [3-atanine was detected.
On oral loading of R.E. with thymine, 1 mmol (kg b.wt) ~ 1, 73 % of the dose was excreted (as thymine + 5-hydroxymethyluracil). After loading with R,S-dihydrothymine 40% was recovered in the 24h urine. Also J3-aminoisobutyric acid (molar amount 6%) was excreted, 95 % having the R-configuration as determined according to van Gennip et al. (1981) .
DHPDH activity values measured in leukocytes are given in Table 1 . All three patients had an almost complete absence of enzyme activity. The parents of R.E. are within, and those of M.S. and B.B. below, the normal range. DISCUSSION From the results described above we conclude that all three patients have a generatised DHPDH deficiency. The high basal excretory values for both thymine and uracil are already highly suggestive of a defect localised at the level of DHPDH. The oral loading tests, proximal and distal to the enzyme block, confirmed this hypothesis and indicated a DHPDH deficiency in the liver. At the enzyme level the deficiency has been proven in the leukocytes of all three patients.
The parents' urinary pyrimidine excretion is not elevated. DHPDH activity of their leukocytes is within or just below the normal range. Therefore we conclude that DHPDH deficiency is inherited in an autosomal recessive mode. Thymine-uraciluria has been described before in a 2-year-old child with a malignant tumour of the brain (Berglund et al., 1979) . The question arises whether the pyrimidines originated from the tumour, as the authors concluded, or whether the patient had an inherited DHPDH deficiency. Very recently another patient with transient epilepsy and generalised seizures was described (Bakkeren et at., 1984) and we know about another one with neurological problems and liver disease (B. Wilcken, personal communication, 1984) . The number of patients with DHPDH deficiency is still too small to conclude whether there is a characteristic clinical picture or not.
